Hepatitis B Clinical Trials

Huntsville : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Garden Grove : Sc Clinical Research, Inc.

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Los Angeles :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Palo Alto : Stanford University

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy While on the Orthotopic Liver Transplant (OLT) List

Sacramento : University Of California Davis Medical Center

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

San Diego : Research and Education Inc.

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

View More »

San Diego : University of California Antiviral Research Center (AVRC)

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

San Diego : University of California Antiviral Research Center (AVRC)

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

San Francisco : University Of California, San Francisco

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

San Francisco : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Hartford : Connecticut Children'S Medical Center

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

New Haven : Yale University School Of Medicine

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Washington : Children'S National Medical Center

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Washington : Georgetown University Hospital

Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients

Gainesville : University Of Florida

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Atlanta : Romero, Rene

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Atlanta : Atlanta Gastroenterology Associates

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Atlanta :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Meridian : Advanced Clinical Research, ID

Hepatitis B Vaccine Clinical Research Study

View More »

Boise : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Indianapolis : Indiana University School Of Medicine / Riley Hospital

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Indianapolis : Indiana University Medical Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Indianapolis : Indiana University Medical Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Mishawaka : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Wichita : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

New Orleans : Tulane University Health Sciences Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

New Orleans : Tulane University Health Sciences Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Baltimore : University of Maryland Institute of Human Virology

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Baltimore : Johns Hopkins School Of Medicine

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Baltimore : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Baltimore : Mercy Medical Center

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Bethesda : National Institute of Allergy and Infectious Diseases

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

View More »

Bethesda : National Institute of Allergy and Infectious Diseases

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Colombia : Gastro Center Of Maryland

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Boston : Shah, Uzma

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Boston : Children'S Hospital Of Boston

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Boston : Beth Israel Deaconess Medical Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Boston : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Boston : BIDMC

FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy

View More »

Boston : Massachusetts General Hospital

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy While on the Orthotopic Liver Transplant (OLT) List

Detroit : Henry Ford Health System

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Detroit : Henry Ford Health System

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Detroit : Henry Ford Health System

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Minneapolis : University Of Minnesota

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Minneapolis :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Kansas City : Kansas City Gastroenterology and Hepatology

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Kansas City : Kansas City Gastroenterology and Hepatology

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

St. Louis : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

St. Louis : Bruce Bacon M.D.

FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy

Manhasset : Biomedical Research Alliance of New York

Chronic Hepatitis B

New York : Clinilabs, Inc.

Do you have Hepatitis B?

View More »

Endwell : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Flushing : Office Of Sing Chan Md

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Flushing : Medical Procare, Pllc

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

New York : Mount Sinai Medical Center

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

New York : CliniLabs

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

New York : Weill Cornell Medical College

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

New York : CliniLabs

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

New York : Weill Cornell Medical College

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

New York : New York School of Medicine

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

New York :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Charlotte : Levine Children'S Hospital At Carolinas Medical Center

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Durham : Duke University Medical Center

FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy

Wilmington : Registry Coordinating Center Updated

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.

Cleveland : Rapid Medical Research, Inc. (RMR)

Hepatitis B Vaccine Clinical Research Study

View More »

Cleveland : University Hospitals Case Medical Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Cleveland : University Hospitals Case Medical Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Cleveland : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Portland : Oregon Health Science University

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Philadelphia : Children'S Hospital Of Philadelphia

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Philadelphia : CRI Worldwide, LLC

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Providence : Rhode Island Hospital

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Nashville : Clinical Research Associates, Inc.

HEPATITIS B (HBV) VACCINE

Nashville : Clinical Research Associates, Inc.

Hepatitis B Vaccine for Type 2 Diabetics

View More »

Nashville : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Houston : Baylor College of Medicine - St. Luke's Episcopal Hospital

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Houston : Texas Children'S Hospital

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Houston : Baylor College of Medicine

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Houston : Baylor College of Medicine

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Houston : Texas Children's Hospital

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Salt Lake City : J. Lewis Research, Inc.

Research study of a Hepatitis B vaccine in adults 20 to 49 years of age, with or without Type 2 Diabetes

View More »

Salt Lake City : University of Utah

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Salt Lake City : University of Utah

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Salt Lake City : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Fairfax : Inova Fairfax Hospital For Children

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Seattle : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Wenatchee : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Bunos Aires : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Box Hill : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Clayton : Monash University, Department of Medicine

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Clayton : Monash University, Dept. of Medicine

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Heidelberg Vic : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Herston : Royal Brisbane and Women's Hospital

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

View More »

Herston : Royal Brisbane and Women's Hospital

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Herston : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Melborne : Monash Medical Centre

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Melbourne : Alfred Hospital

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Melbourne : Austin Health

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Melbourne : Alfred Hospital, Department of Gastroenterology

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Melbourne : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Melbourne : The Alfred Hospital

A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients

Melbourne : The Alfred Hospital

HIV-HBV Co-Infection and Liver Disease

Nedlands : Linear Clinical Research Ltd

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Nedlands : Royal Perth Hospital

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Nedlands : Royal Perth Hospital

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

North Adelaide : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

South Granville : Merck Sharp & Dohme/Australia

A Study of the Safety and Efficacy of PEG-Intron™ Versus PEGASYS™ in Participants With Chronic Hepatitis B (P08450 AM1)

St Albans : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Sydney : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Brussels : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Bruxelles : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Gent : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Pleven :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Plodiv : University Multiprofile Hospital for Active Treatment "Sveti Georgi"

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Plovdiv :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Sofia :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Sofia : Multiprofile Hospital for Active Treatment "Tokuda Hospital"

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

View More »

Sofia : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Stara Zagora :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Varna :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Varna : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Calgary : University of Calgary, Heritage Medical Research Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Calgary : University of Calgary, Heritage Medical Research Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Edmonton : University of Alberta Hospital

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Edmonton : University of Alberta Hospital

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Laval : Algorithme Pharma, Inc.

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

View More »

Montreal : Algorithme Pharma

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Montreal : Algorithme Pharma, Inc.

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Montreal :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Ottawa : The Ottawa Hospital, General Campus

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Quebec City : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

St. Romuald : Pro-recherche

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Ste-Foy : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Sudbury : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Toronto : Toronto General Hospital

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Toronto : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Truro : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Vancouver : Downtown Infectious Diseases Clinic (University of British Columbia)

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Beijing : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Beijing : Local Institution

Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

Beijing : National Center for AIDS/STD Control and Prevention, China CDC

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

Beijing : Beijing Ditan Hospita

EFFORT Extension Study

Beijing : Beijing Friendship Hospital Attached To The Capital Medical University

EFFORT Extension Study

View More »

Beijing : Department of Infectious Disease, First Hospital of Peking University

EFFORT Extension Study

Beijing : 302 Military Hospital Of China

EFFORT Extension Study

Beijing : BeiJing YouAn Hospital ,Capital Medical University

EFFORT Extension Study

Beijing : People's Hospital Under Beijnig University

EFFORT Extension Study

Chang Chun : Hepatobiliary Disease Hospital of Jilin Province

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Changchun : First Hospital .Jilin Unniversity

EFFORT Extension Study

Changsha : Xiangya Hospital Central-South Univrsity

EFFORT Extension Study

Changshu : Local Institution

Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

Chengdu : West China Hospital.SiChuan University

EFFORT Extension Study

Chongqing : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Chongqing : The Second Affiliated of ChongQing University of Medical Science

EFFORT Extension Study

Chongqing : Southwest Hospital

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Daqing : Local Institution

Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

Foshan : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Guangzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Guangzhou : No. 8 People's Hospital In GuangZhou

EFFORT Extension Study

Guangzhou : The Third Hospital of Sun Yat-Sen University

EFFORT Extension Study

Guangzhou : Department of Infectious Disease, Nanfang Hospital

EFFORT Extension Study

Hangzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Hangzhou : The First Affiliated Hospital of College of Medicine, Zhejiang University

EFFORT Extension Study

Hangzhou : The Sixth People's Hospital of Hangzhou

EFFORT Extension Study

Harbin : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Hong Kong : Department of Medicine, Queen Mary Hospital

Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB

Jinan : JiNan Infectious Diseases Hospital

EFFORT Extension Study

Liuzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Nan Jing : The Second Affiliated Hospital of the Southeast University

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Nanchang : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Nanjing : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Nanjing : No.81 Hospital of PLA

EFFORT Extension Study

Nanning : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Nanyang : Nanyang Central Hospital

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Ordos : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Shanghai : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Shanghai : Changhai Hospital affiliated to Second Military Medical University

EFFORT Extension Study

Shanghai : Huashan Hospital，Fudan University

EFFORT Extension Study

Shanghai : Shanghai Ruijin Hospital

EFFORT Extension Study

Shanghai : No.85 Hospital of PLA

EFFORT Extension Study

Shengyang : ShengJing Hospital of China Medical University

EFFORT Extension Study

Shenzhen : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Shijiazhuang : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Shijiazhuang : The Fifth Hospital of Shijiazhuang

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Suzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Tianjin : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Urumqi : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Wenzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Wuhan : Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology

EFFORT Extension Study

Wuxi : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Xiamen : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Xian : Tangdu Hospital

EFFORT Extension Study

Yangzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Zhaoqing : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Zhenjiang : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Paris : Hopital Cochin CIC de vaccinologie

Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients

Berlin : Charite CVK

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Berlin : Leberzentrum am Checkpoint

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Berlin : Private Practice

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Bonn : Universitaetsklinikum Bonn

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Duesseldorf : Zentrum für HIV und Hepatitis

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

View More »

Essen : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Frankfurt : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Frankfurt : J.W. Goethe Universitaetsklinikum

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Freiburg : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Halle : Martin-Luther University Halle-Wittenberg

Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on Hemodialysis

Hamburg : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Hamburg : ifi Studien und Projekte GmbH

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Hamburg : Universitaetsklinikum Hamburg Eppendorf

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Hamburg : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Hannover : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Hannover : Medizinische Hochschule Hannover

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Heidelberg : Universitaetsklinik Heidelberg

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Herne : Gastroenterologische Gemeinschaftspraxis

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Herne : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Kiel : Gastroenterologische Gemeinschaftspraxis

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Leipzig :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

Leipzig : Universitaetsklinikum Leipzig

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Leipzig : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Leverkusen : Gemeinschaftspraxis Gastroenterologie

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Mainz : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Mainz : Universitätsmedizin Mainz, I. Med. Klinik und Poliklinik

Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen

Mainz : Universitaetsklinikum Mainz

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Muenchen : Klinikum der LMU Grosshadern

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Muenster : Centrum interdisziplinaere Medizin

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Starnberg : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Tuebingen : Universitaetsklinik Tuebingen

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Ulm : Universitaetsklinikum Ulm

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Wuppertal : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Thesaloniki : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Kowloon : Princess Margaret Hospital

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

New Territories : Tuen Mun Hospital

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Pokfulam : Queen Mary Hospital

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Shatin : Prince of Wales Hospital

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Tai Po : Alice Ho Miu Ling Nethersole Hospital

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Chandigarh : School of Public Health, Post Graduate Institute of Medical Education and Research

Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

Guwahati : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Hyderabad : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Vijaywada : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Beer-Sheva : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Haifa : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Jerusalem : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Petach Tikva : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Zefat : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

View More »

Zefat : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Bari : Updated

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Bologna : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Firenze : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Genova :

A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Patients With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable HBV DNA Suppression

Messina :

A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Patients With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable HBV DNA Suppression

View More »

Milano : Updated

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Milano :

A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Patients With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable HBV DNA Suppression

Modena : A.O.U. Policlinico Università di Modena e Reggio Emilia

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Napoli : Updated

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Napoli :

A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Patients With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable HBV DNA Suppression

Padova : Updated

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Padova : Az. Ospedaliera Universitaria di Padova

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Palermo : Updated

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Parma : Updated

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Pisa : Updated

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Pisa :

A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Patients With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable HBV DNA Suppression

Pisa : Azienda Ospedaliero Universitaria Pisana

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Roma : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Torino : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Torino : Az. Ospedaliera S.Giovanni Battista di Torino

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Udine :

A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Patients With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable HBV DNA Suppression

Bucheon : Soon Chun Hyang University Bucheon Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Busan : Dong-A University Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Busan : Kosin University Gospel Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Busan : Inje University Haeundae Paik Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Cheonan : Dankook University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

View More »

Chuncheon : Chuncheon Sacred Heart Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Daegu : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Daegu : Kyungpook National University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Daegu : Yeungnam University Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Daegu : Kyungpook National University

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Guri : Hanyang University Guri Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Incheon : Gachon University Gil Hospital, Department of Pediatrics

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Jeju : Jeju National University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seongnam : SKChemicals

A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients

Seoul : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Seoul : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Seoul : Hanyang University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Inje University Sanggye Paik Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Kangbuk Samsung Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Kangdong Sacred Heart Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Kangnam Severance Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Konkuk University Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Kyunghee university Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Severance Children's Hospital

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Seoul : Shinchon Severance Hospital

HBsAg Related Response Guided Therapy

Seoul : Department of clinical pharmacology and therapeutics

Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection

Sungnam : Bundang CHA medical center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Uijeongbu : Uijeongbu St.Mary's Hospital

A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)

Uijeongbu : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Wonju : Wonju Christian Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Yangsan : Busan National University Yangsan Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Yangsan-si : Pusan National University Yangsan Hospital

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Rotterdam : Erasmus Medical Center

PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients

Auckland : Auckland Clinical Studies

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Grafton : Auckland Clinical Studies

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Grafton : Aukland Clinical Studies

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Hamilton : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Rotorua : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

View More »

Takapuna Auckland : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Wellington : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Bydgoszcz : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Bydgoszcz : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Bydgoszcz : Collegium Medicum Uniwersytet im. Mikołaja Kopernika

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Bytom :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Krakow : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

View More »

Krakow : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Krakow :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Lancut :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Myslowice :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Poznan : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Raciborz :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Szczecin : Samodzielny Publiczny Wojewódzki Szpital Zespolony

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Warsaw : Wojewódzki Szpital Zakaźny

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Wroclaw : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Wrocław : NZOZ Centrum Badan Klinicznych

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Bucharest : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Bucharest : Grigore Alexandrescu Emergency Clinical Hospital for Children

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Bucharest : Fundeni Clinical Institute - Constantinesco

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Bucharest : National Institute of Infectious Diseases

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Constanta : Clinical Infectious Diseases Hospital of Constanta

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

View More »

Craiova : "Victor Babes" Clinical Hospital of Infectious Diseases and Pneumophtisology

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Iasi : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Timisoara : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Moscow : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Moscow : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Novokuznetsk : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Samara :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Samara : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

View More »

St Petersburg :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

St. Petersburg : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Stavropol :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Barcelona : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

El Palmar : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Changhua : Changhua Christian Hospital

Comparison Between Lamivudine and Entecavir Treatment in Patients

ChiaYi : Chia-Yi Christian

Comparison Between Lamivudine and Entecavir Treatment in Patients

Chia-Yi : Chia-Yi Christine Hospital

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Kaohsiung : E-Da Hospital

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Taichung : Taichung Veterans General Hospital

Comparison Between Lamivudine and Entecavir Treatment in Patients

View More »

Taichung : Taichung Veterans General Hospital

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Tainan : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Taipei : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Taipei : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Taipei : National Taiwan University Hospital Department of Internal medicine

Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B

Taipei : Department of Internal Medicine

Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C

Taipei : Taipei Veterans General Hospital-Division of Gastroenterology, Division of Oncology

Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B

Taoyuan : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Yunlin County : National Taiwan University Hospital Yun-Lin Branch

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Bangkok :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Bangkok : Bhumibol Adulyadej Hospital

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

Chantaburi : Prapokklao Hospital

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

Chiang Mai :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Chiang Rai : Chiangrai Prachanukroh Hospital

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

View More »

Chonburi : Chonburi Regional Hospital

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

Khon Kaen :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Phayao : Phayao Provincial Hospital

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

Songkhla :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Kyiv : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Birmingham : University Hospitals Birmingham NHS Foundation Trust

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Birmingham : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Birmingham : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

London : University College London Hospital

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

London : Grahame Hayton Unit

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

View More »

London : Institute of Liver Studies, King's College Hospital

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

London : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

London : Updated

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Nottingham : Nottingham University Hospitals NHS Trust - Queens Medical Centre

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B